As you plan for 2027, understanding how to generate and apply Real-World Evidence (RWE) across diverse healthcare systems is becoming increasingly important to support market access, development, and regulatory decision-making throughout the product lifecycle.

This virtual conference will explore how organizations can strengthen their evidence strategies across Asia-Pacific by leveraging local data sources, navigating evolving reimbursement landscapes, and building fit-for-purpose evidence generation capabilities.

Key topics include:

• Reimbursement and market access strategies through RWE in China and Taiwan
• How evolving pricing, reimbursement, and health technology assessment requirements are shaping evidence expectations across Greater China
• Unlocking the value of regional EHR and hospital data to generate scalable, decisiongrade evidence
• How registries can help address critical evidence gaps and complement existing realworld data sources
• Practical approaches for transforming fragmented healthcare data into regulatory-ready evidence

Across our country-focused sessions, IQVIA experts from Mainland China and Taiwan, Japan, and Korea will share local perspectives, emerging trends, and practical examples.​

Join us to learn how regional data assets, innovative evidence approaches, and early planning can help accelerate clinical development and maximize the value of RWE in 2027 and beyond.

Virtual Event
This event will be held on our virtual platform.  Information on how to access the conference will be shared once you've registered.